BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8353138)

  • 1. Estrogen regulation of proto-oncogenes coding for nuclear proteins.
    Weisz A; Bresciani F
    Crit Rev Oncog; 1993; 4(4):361-88. PubMed ID: 8353138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells.
    Cicatiello L; Sica V; Bresciani F; Weisz A
    Receptor; 1993; 3(1):17-30. PubMed ID: 8348080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression.
    Landers JP; Spelsberg TC
    Crit Rev Eukaryot Gene Expr; 1992; 2(1):19-63. PubMed ID: 1543897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
    Li H; Xie P; Li G; Hao L; Xiong Q
    Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
    Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
    J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues.
    Chalbos D; Philips A; Rochefort H
    Semin Cancer Biol; 1994 Oct; 5(5):361-8. PubMed ID: 7849264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
    Whisler RL; Chen M; Beiqing L; Carle KW
    Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential EGF action on nuclear protooncogenes in human endometrial carcinoma RL95-2 cells.
    Sallot M; Ordener C; Lascombe I; Propper A; Adessi GL; Jouvenot M
    Anticancer Res; 1996; 16(1):401-6. PubMed ID: 8615644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene modulation accompanying differentiation of normal versus malignant keratinocytes.
    Yaar M; Gilani A; DiBenedetto PJ; Harkness DD; Gilchrest BA
    Exp Cell Res; 1993 Jun; 206(2):235-43. PubMed ID: 8500546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways in the induction of c-fos and c-jun proto-oncogenes by 3-methylcholanthrene.
    Ainbinder E; Bergelson S; Daniel V
    Recept Signal Transduct; 1997; 7(4):279-89. PubMed ID: 9633828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
    Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
    Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
    Kirkland JL; Murthy L; Stancel GM
    Mol Pharmacol; 1993 May; 43(5):709-14. PubMed ID: 8502228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
    Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
    J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-induced proto-oncogene and suppressor gene expression in the hamster kidney: significance for estrogen carcinogenesis.
    Hou X; Li JJ; Chen W; Li SA
    Cancer Res; 1996 Jun; 56(11):2616-20. PubMed ID: 8653706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.
    Zheng X; Hendry WJ
    Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
    Bortner DM; Langer SJ; Ostrowski MC
    Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus.
    Weisz A; Bresciani F
    Mol Endocrinol; 1988 Sep; 2(9):816-24. PubMed ID: 3173352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.